KMT2A and leukemia: These findings are consistent with the previously proposed dominant negative mechanism in MLL1F leukemias, where MLL1F proteins, lacking the catalytic SET domain, inhibit the enzymatic activity of WT MLL1 encoded from the unaffected allele (45, 96).